Dynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis

Virology

Volumn 427, Issue 2, 2012, Pages 135-143

  Gu, Rui ^a   Shampang, Anae ^a   Reilly, Andrew ^a   Fisher, Dusti ^b   Glass, William ^b   Ramsingh, Arlene I ^a  

^a WADSWORTH CENTER   (United States)

^b CENTOCOR INC   (United States)

Author keywords

Coxsackievirus; Cytokines; Gene expression; Pancreatitis; Therapeutic target; Transcriptional profiling

Indexed keywords

GAMMA INTERFERON ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL3 GENE; CCR5 GENE; CHRONIC PANCREATITIS; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; CXCL10 GENE; CXCR3 GENE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GATA3 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; IFNGR GENE; IFNGR1 GENE; IMMUNE RESPONSE GENE; IMMUNOMODULATION; INTERFERON GAMMA GENE; INTERLEUKIN 10 GENE; INTERLEUKIN 17 RECEPTOR BETA GENE; INTERLEUKIN 18 RECEPTOR ALPHA GENE; INTERLEUKIN 22 BETA GENE; INTERLEUKIN 27 BETA GENE; INTERLEUKIN 6 RECEPTOR ALPHA GENE; INTERLEUKIN 6 SIGNAL TRANSDUCER GENE; INTERMETHOD COMPARISON; MALE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOCS3 GENE; SOCS5 GENE; TBET GENE; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 4 GENE; TOLL LIKE RECEPTOR 5 GENE; TOLL LIKE RECEPTOR 7 GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; VIRUS TITRATION;

ANIMALS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PANCREAS; PANCREATITIS, CHRONIC;

COXSACKIEVIRUS;

EID: 84858749691     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.02.009     Document Type: Article

References (23)

1. Bhatia M. Apoptosis of pancreatic acinar cells in acute pancreatitis: is it good or bad?. J. Cell Mol. Med. 2004, 8:402-409.
2. Caggana M., Chan P., Ramsingh A. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 1993, 67:4797-4803.
3. Chapman N.M., Ramsingh A.I., Tracy S. Genetics of coxsackievirus virulence. Curr. Top. Microbiol. Immunol. 1997, 223:227-258.
4. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J. Immunol. 2008, 180:5771-5777.
5. Gu R., Shampang A., Reilly A., Fisher D., Glass W., Ramsingh A.I. IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis. Virology 2009, 395:77-86.
6. Henke A., Zell R., Ehrlich G., Stelzner A. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J. Virol. 2001, 75:8187-8194.
7. Horwitz M.S., La C.A., Fine C., Rodriguez E., Ilic A., Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 2000, 6:693-697.
8. Huber S., Ramsingh A.I. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004, 17:358-369.
9. Kingsnorth A., O'Reilly D. Acute pancreatitis. BMJ 2006, 332:1072-1076.
10. Liu S.F., Malik A.B. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290:L622-L645.
11. Mergener K., Baillie J. Chronic pancreatitis. Lancet 1997, 350:1379-1385.
12. Ostrowski S.E., Reilly A.A., Collins D.N., Ramsingh A.I. Progression or resolution of coxsackievirus B4-induced pancreatitis - a genomic analysis. J. Virol. 2004, 78:8229-8237.
13. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929-979.
14. Potvin D.M., Metzger D.W., Lee W.T., Collins D.N., Ramsingh A.I. Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J. Virol. 2003, 77:8272-8279.
15. Ramsingh A.I. CVB-induced pancreatitis and alterations in gene expression. Curr. Top. Microbiol. Immunol. 2008, 323:241-258.
16. q locus of the major histocompatibility complex. Virus Res. 1989, 14:347-358.
17. Ramsingh A.I., Lee W.T., Collins D.N., Armstrong L.E. Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J. Virol. 1997, 71:8690-8697.
18. Ramsingh A.I., Lee W.T., Collins D.N., Armstrong L.E. T cells contribute to disease severity during coxsackievirus B4 infection. J. Virol. 1999, 73:3080-3086.
19. Stevens T., Conwell D.L., Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am. J. Gastroenterol. 2004, 99:2256-2270.
20. Szalay G., Sauter M., Hald J., Weinzierl A., Kandolf R., Klingel K. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am. J. Pathol. 2006, 169:2085-2093.
21. Tracy S., Gauntt C. Group B coxsackievirus virulence. Curr. Top. Microbiol. Immunol. 2008, 323:49-63.
22. Triantafilou K., Orthopoulos G., Vakakis E., Ahmed M.A., Golenbock D.T., Lepper P.M., Triantafilou M. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 2005, 7:1117-1126.
23. Whitcomb D.C. Clinical practice. Acute pancreatitis. N. Engl. J. Med. 2006, 354:2142-2150.